Almac Group to Host Clinical Trial Supply Workshop in London
Craigavon, UK, 15 January 2019 – Almac Clinical Services, part of the global contract pharmaceutical development and manufacturing organisation the Almac Group, is delighted to invite participants from the Biopharma Industry to join its upcoming Workshop on Thursday 31st January.
Hosted at Pullman London St Pancras Hotel on Thursday, 31st January 2019, the complimentary workshop will examine “Clinical Trial Supply and Technology: A proven approach to achieve supply chain harmony.” Leading the workshop will be Almac’s subject matter experts, including Meryvn Preston, Supply Chain Management Project Group Manager, Kelly O’Donnell, Supply Chain Manager and Brian Mullin, Clinical Project Services Manager. Andrew Scott, Head of Logistics (EU), Almac Clinical Services will also lead a BREXIT panel discussion.
Almac understands the challenges faced by biotechnology and pharmaceutical companies in an ever-evolving industry. Using real-life scenarios and interactive group discussion, participants will learn how to achieve an integrated, simplified and optimised clinical supply chain as well as discuss how to overcome the barriers posed by the management of clinical supplies.
Speaker, Mervyn Preston, commented on the upcoming workshop: “We are excited to be hosting this unique workshop which will give participants an opportunity to understand our facilities, capabilities and services. The primary goal of this workshop is for attendees to leave with a wealth of knowledge on how to execute their trials more effectively based on a solid understanding of having a harmonised physical and digital clinical supply chain.”
As industry leading experts, Almac hopes that the information presented during this complimentary workshop can help to guide clinical supply professionals throughout their clinical supply journey.
To find out more and to sign up to receive information about upcoming events, please visit: https://www.almacgroup.com/clinical-services/workshop/
About Almac Group
A unique culture delivering exceptional solutions
The Almac Group is an established contract development and manufacturing organisation providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally. Its innovative services range from R&D, biomarker discovery development and commercialisation, API manufacture, formulation development, clinical trial supply, IRT (IVRS/IWRS) through to commercial-scale manufacture.
The international company is a privately owned organisation which has grown organically over the past five decades now employing over 5,000 highly skilled personnel across 17 facilities including Europe, the US and Asia.
The company has a global reputation for excellence built over 50 years of client service, delivering expertise right across the drug development lifecycle and offering a tailored solution to each of our clients.
- Almac Group